Acute myeloid leukaemia M0: Haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: An analysis in 241 patients

British Journal of Haematology

Volumn 113, Issue 3, 2001, Pages 737-745

  Béné, Marie Christine ^a   Bernier, Michel ^b   Casasnovas, René Olivier ^c   Castoldi, Gianluigi ^d   Doekharan, Dew ^e   Van Der Holt, Bronno ^e   Knapp, Walter ^f   Lemež, Petr ^g   Ludwig, Wolf Dieter ^h   Matutes, Estella ⁱ   Orfao, Alberto ^j   Schoch, Claudia ^k   Sperling, Christian ^h   Van't Veer, Mars B ^e  

^a UNIVERSITÉ DE LORRAINE   (France)

^b JULES BORDET INSTITUTE   (Belgium)

^c Service d'Hematologie   (France)

^d UNIVERSITY OF FERRARA   (Italy)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF VIENNA   (Austria)

^g Hospital Jihlava   (Czech Republic)

^h HUMBOLDT UNIVERSITY   (Germany)

ⁱ ROYAL MARSDEN HOSPITAL   (United Kingdom)

^j UNIVERSITY OF SALAMANCA   (Spain)

^k UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

AML M0; Clinical characteristics; Cytogenetics; Immunophenotype

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL; CHILD; CHROMOSOME 11; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CYTOGENETICS; FEMALE; HUMAN; IMMUNOPHENOTYPING; INFANT; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; LIVER; LYMPH NODES; MALE; MIDDLE AGED; PLATELET COUNT; SPLEEN; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 0034990778     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02801.x     Document Type: Article

References (38)

1. Ultrastructure and cytochemistry of the developing neutrophil
2. Proposals for the immunological classification of acute leukemias
3. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias
4. Impact of immunophenotyping on management of acute leukemias
5. Acute leukaemia cytochemical profile: Diagnostic and clinical implications
6. Proposals for the recognition of minimally differentiated acute myeloid leukaemia
7. Diagnosis of acute leukemia varieties by peroxidase reaction studied by electron microscopy. Its value and its limitations
8. Association between morphology, karyotype and clinical features in myeloid leukemias
9. Phenotypic, genotypic, cytochemical and ultrastructural characterization of acute undifferentiated leukemia
10. Surface marker expression in adult myeloid leukaemia: Correlations with initial characteristics, morphology and respons to therapy
11. Clinical significance of multidrug resistence p-glycoprotein expression on acute non lymphoblastic leukemia cell at diagnosis
12. Acute myeloid leukemia with minimal differentiation, a multiple parameter study
13. - leukemic progenitors
14. Clinical significance of surface antigen expression in children with acute myeloid leukemia, results of study AML-BFM-87
15. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia. Correlation with chemico-biological findings
16. The relation between morphology and other features of acute myeloid leukaemia and their prognostic significance
17. World Health Organisation classification of neoplastic diseases of the haemotopoietic and lymphoid tissue: Report of the clinical advisory committee meeting - Airlie House Virginia, November 1997
18. Minimally differentiated acute myeloid leukemia in Taiwan predominantly occurs in children less than 3 years and adults between 51 and 70 years
19. Acute unclassifiable leukaemia in adults, demonstrating myeloid antigen and myeloperoxydase proteins
20. Minimally differentiated acute non lymphocytic leukemia, a distinct entity
21. Heterogeneity in acute undifferentiated leukemia
22. Cytochemical examinations of cultivated unclassified leukaemic cells
23. Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors
24. Determination of ultrastructural peroxidases and immunological membrane markers in the diagnosis of acute leukemias
25. The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia
26. Minimally differentiated acute myeloid leukemia (AML M0) with extensive erythrophagocytosis and del (20) (q11) chromosome abnormality
27. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: The Eastern Cooperative Oncology Group experience
28. AML-M0 clinical entity or waste basket for immature blastic leukemias? A description of 14 patients
29. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB M0): A study of eleven cases
30. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML M0)
31. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia
32. Electron microscopy, a contribution to further classification of acute unclassifiable childhood leukaemia
33. Minimally differentiated acute myeloid leukaemia (AML-M0) Cytochemical, immunophenotypic and cytogenetic analysis in 19 cases
34. Minimally differentiated acute myeloid leukemia (AML M0): Comparison of 25 cases with other French-American-British subtypes
35. Acute myeloblastic leukemia with minimal myeloid differentiation: Phenotypical and ultrastructural characteristics
36. Purification of pluripotent hematopoietic stem cells: Past and present
37. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in the context of P glycoprotein function, maturation stage, and cytogenetics